Loss of Tolerance and Autoimmunity Affecting Multiple Organs in STAT5A/5B-Deficient Mice

Journal of Immunology

Volumn 171, Issue 10, 2003, Pages 5042-5050

  Snow, Jonathan W ^a,b   Abraham, Ninan ^a   Ma, Melissa C ^a   Herndier, Brian G ^a   Pastuszak, Alexander W ^a,b   Goldsmith, Mark A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR BETA; ISOPROTEIN; PROTEIN BCL 2; RAG1 PROTEIN; RECEPTOR SUBUNIT; STAT5 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; BONE MARROW; COLON DISEASE; GENE; GENE LOSS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; INTERLEUKIN 2 RECEPTOR BETA GENE; KIDNEY DISEASE; LIVER DISEASE; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RECOMBINATION ACTIVATING GENE 1; SIGNAL TRANSDUCTION; STAT5A GENE; STAT5B GENE; SURVIVAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0242580058     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.10.5042     Document Type: Article

References (66)

1. Marrack, P., J. Kappler, and B. L. Kotzin. 2001. Autoimmune disease: why and where it occurs. Nat. Med. 7:899.
2. O'Shea, J. J., A. Ma, and P. Lipsky. 2002. Cytokines and autoimmunity, Nat. Rev. Immunol. 2:37.
3. Durkin, H. G., and B. H. Waksman, 2001. Thymus and tolerance: is regulation the major function of the thymus? Immunol. Rev. 182:33.
4. + T-cell subsets in auto-immunity. Curr. Opin. Immunol. 9:872.
5. Falcone, M., and N. Sarvetnick. 1999. Cytokines that regulate autoimmune responses. Curr. Opin. Immunol. 11:670.
6. Van Parijs, L., and A. K. Abbas. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280:243.
7. Suzuki, H., T. M. Kündig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. Simard, P. S. Ohashi, H. Griesser, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268:1472.
8. Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521.
9. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253.
10. Nakajima. H., E. W. Shores, M. Noguchi, and W. J. Leonard. 1997. The common cytokine receptor γ chain plays an essential role in regulating lymphoid homeostasis. J. Exp. Med. 185:189.
11. Gaffen, S. L. 2001. Signaling domains of the interleukin 2 receptor. Cytokine 14:63.
12. Lin, J. X., and W. J. Leonard. 2000. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 19:2566.
13. Nelson, B. H. 2002. Interleukin-2 signaling and the maintenance of self-tolerance. Curr. Dir. Autoimmun. 5:92.
14. Bromberg, J., and J. E. Darnell, Jr. 2000. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19:2468,
15. Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331.
16. Takeda, K., B. E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, I. Forster, and S. Akira. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39.
17. + T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity 11:463.
18. Teglund, S., C. McKay, E. Schuetz, J. M. van Deursen, D. Stravopodis, D. Wang, M. Brown, S. Bodner, G. Grosveld, and J. N. Ihle. 1998. Stat5a and Stat5b proteins have essential and nonessential of redundant, roles in cytokine responses. Cell 93:841.
19. Liu, X., G. W. Robinson, K. U. Wagner, L. Garrett, A. Wynshaw-Boris, and L. Hennighausen. 1997. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11:179.
20. Udy, G. B., R. P. Towers, R. G. Snell, R. J. Wilkins, S. H. Park, P. A. Ram. D. J. Waxman. and H. W. Davey. 1997. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 94:7239.
21. Feldman, G. M., L. A. Rosenthal, X. Liu, M. P. Hayes. A. Wynshaw-Boris. W. J. Leonard. L. Hennighausen, and D. S. Finbloom. 1997. STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood 90:1768.
22. Nakajima, H., X. W. Liu, A. Wynshaw-Boris. L. A. Rosenthal, K. Imada, D. S. Finbloom, L. Hennighausen, and W. J. Leonard. 1997. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction. Immunity 7:691.
23. Imada, K., E. T. Bloom, H. Nakajima, J. A. Horvath-Arcidiacono, G. B. Udy, H. W. Davey, and W. J. Leonard. 1998, Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J. Exp. Med. 188:2067.
24. Snow, J. W., N. Abraham. M. C. Ma, N. W. Abbey, B. Herndier, and M. A. Goldsmith. 2002. STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells. Blood 99:95.
25. Bunting, K. D., H. L. Bradley, T. S. Hawley, R. Moriggl, B. P. Sorrentino, and J. N. Ihle. 2002. Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5. Blood 99:479.
26. Zhang. S., S. Fukuda, Y. Lee. G. Hangoc, S. Cooper, R. Spolski. W. J. Leonard, and H. E. Broxmeyer. 2000. Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling. J. Exp. Med. 192:719.
27. -/- mice due to decreased survival of early erythroblasts. Blood 98:3261.
28. L induction. Cell 98:181.
29. Kieslinger, M., I. Woldman, R. Moriggl, J. Hofmann, J. C. Marine, J. N. Ihle, H. Beug, and T, Decker. 2000. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev. 14:232.
30. Moriggl, R., V. Sexl, R. Piekorz, D. Topham, and J. N. Ihle. 1999. Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. Immunity 11:225.
31. Moriggl, R., D. J. Topham, S. Teglund. V. Sexl, C. McKay, D. Wang, A. Hoffmeyer, J. van Deursen, M. Y. Sangster, K. D. Bunting, et al. 1999. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10:249.
32. Kagami, S., H. Nakajima, K, Kumano, K, Suzuki, A. Suto, K. Imada, H. W. Davey, Y. Saito, K. Takatsu, W. J. Leonard, and I. Iwamoto. 2000. Both Stat5a and Stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue. Blood 95:1370.
33. Kagami, S., H. Nakajima, A. Suto, K. Hirose, K. Suzuki, S. Morita, I. Kato, Y, Saito, T. Kitamura, and I. Iwamoto. 2001. Stat5a regulates T helper cell differentiation by several distinct mechanisms. Blood 97:2358.
34. Van Parijs, L., Y. Refaeli, J. D. Lord, B. H. Nelson, A. K, Abbas, and D. Baltimore. 1999. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11:281.
35. Sexl, V., R. Piekorz, R. Moriggl, J. Rohrer, M. P. Brown, K. D. Bunting, K. Rothammer, M. F. Roussel, and J. N. Ihle. 2000. Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of Stat5. Blood 96:2277.
36. Ernst, J. D., L. Yang, J. L. Rosales, and V. C. Broaddus. 1998. Preparation and characterization of an endogenously fluorescent annexin for detection of apoptotic cells. Anal. Biochem. 260:18.
37. Akashi, K., D. Traver, T. Miyamoto, and I. L. Weissman. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193.
38. Kondo, M., I. L. Weissman, and K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661.
39. Contractor, N. V., H, Bassiri, T. Reya, A, Y. Park, D. C. Baumgart, M. A. Wasik, S. G, Emerson, and S. R. Carding. 1998. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J. Immunol. 160:385.
40. Reya, T., N. V. Contractor, M. S. Couzens, M. A. Wasik, S. G. Emerson, and S. R. Carding. 1998. Abnormal myelocytic cell development in interleukin-2 (IL-2)-deficient mice: evidence for the involvement of IL-2 in myelopoiesis. Blood 91:2935.
41. Papiernik, M., M. L. de Moraes, C. Pontoux, F. Vasseur, and C. Penit. 1998. Regulatory CD4 T cells: expression of IL-2R α chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10:371.
42. + regulatory T cell function. J. Exp. Med. 196:851.
43. Malek, T., A. Yu, V. Vincek, P. Scibelli, and L. Kong. 2002. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice: implications for the nonredundant function of IL-2. Immunity 17:167.
44. Maloy, K. J., and F. Powrie. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:816.
45. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389.
46. Chatenoud, L., B. Salomon. and J. A. Bluestone. 2001. Suppressor T cells-they're back and critical for regulation of autoimmunity! Immunol. Rev. 182:149.
47. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16:311.
48. Young, N. S., and J. Maciejewski. 1997. The pathophysiology of acquired aplastic anemia. N. Engl. J. Med. 336:1365.
49. Young, N. S., J. L. Abkowitz, and L. Luzzatto. 2000. New insights into the pathophysiology of acquired cytopenias. In American Society of Hematology, Vol. Hematology 2000. American Society of Hematology. San Francisco, p. 18.
50. Croisille, L., G. Tchemia, and N. Casadevall. 2001. Autoimmune disorders of erythropoiesis. Curr. Opin. Hematol. 8:68.
51. Rosti, V. 2000. The molecular basis of paroxysmal nocturnal hemoglobinuria. Haematologiea 85:82.
52. Santamaria, P. 2001. Effector lymphocytes in autoimmunity. Curr. Opin. Immunol. 13:663.
53. + T cells in organ specific autoimmune diseases: insight from transgenic mouse models. Immunol. Rev. 169:81.
54. + T cells in autoimmune diabetes through the use of TCR transgenic mice. Immunol. Rev. 169:55.
55. Fujii. H., K. Ogasawara, H. Otsuka, M. Suzuki, K. Yamamura, T. Yokochi, T. Miyazaki, H. Suzuki. T. W. Mak, S. Taki, and T. Taniguchi. 1998. Functional dissection of the cytoplasmic subregions of the IL-2 receptor βc chain in primary lymphocyte populations. EMBO J. 17:6551.
56. Van Parijs, L., A. Ibraghimov, and A. K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
57. Van Parijs, L., A. Biuckians, A. Ibragimov, F. W. Alt, D. M. Willerford, and A. K. Abbas. 1997. Functional responses and apoptosis of CD25 (IL-2Rα)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158:3738.
58. Suzuki, H., Y. W. Zhou, M. Kato. T. W. Mak, and I. Nakashima, 1999. Normal regulatory α/β T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor β in vivo. J. Exp. Med. 190:1561.
59. + T cells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 31:1637.
60. Asano, M., M. Toda. N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387.
61. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1969.
62. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162:5317.
63. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164:183.
64. Zamorano, J., H. Y. Wang, R. Wang, Y. Shi, G. D. Longmore, and A. D. Keegan. 1998. Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression. J. Immunol. 160:3502.
65. Lord, J. D., B. C. McIntosh, P. D. Greenberg, and B. H, Nelson. 2000. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J. Immunol. 164:2533.
66. Kim, H. P., J. Kelly, and W. J. Leonard. 2001. The basis for IL-2-induced IL-2 receptor α chain gene regulation: importance of two widely separated IL-2 response elements. Immunity 15:159.